scispace - formally typeset
C

C. Gopi Mohan

Researcher at Amrita Institute of Medical Sciences and Research Centre

Publications -  58
Citations -  1500

C. Gopi Mohan is an academic researcher from Amrita Institute of Medical Sciences and Research Centre. The author has contributed to research in topics: Virtual screening & Docking (molecular). The author has an hindex of 20, co-authored 52 publications receiving 1214 citations. Previous affiliations of C. Gopi Mohan include University of Bath & Amrita Vishwa Vidyapeetham.

Papers
More filters
Journal ArticleDOI

Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options.

TL;DR: This review is intended to raise awareness of several novel approaches that can be considered further for combating drug resistant P. aeruginosa infections.
Journal ArticleDOI

Antiobesity and lipid lowering effects of Glycyrrhiza chalcones: experimental and computational studies.

TL;DR: The results indicate the potential of the chalcone scaffold as a source of PL inhibitors for preventing obesity and the antiobesity and lipid lowering effects of 7 and 10 in high fat diet (HFD) fed male SD rats.
Journal ArticleDOI

Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents

TL;DR: A novel series of pyrazole derivatives were synthesized and evaluated in vivo for their anti- inflammatory activity in carrageenan-induced rat paw edema model and showed comparable anti-inflammatory activity to Nimesulide, the standard drug taken for the studies.
Journal ArticleDOI

Inhibition of Acetylcholinesterase by Coumarins: The Case of Coumarin 106

TL;DR: This is the first report where AChE inhibitory activity has been associated with coumarin 106, and proof has been given of its convenience as a lead molecule.
Journal ArticleDOI

Crystal structure of protoporphyrinogen oxidase from Myxococcus xanthus and its complex with the inhibitor acifluorfen

TL;DR: There is a discrepancy between the dimerization state of the protein in solution and in the crystal, and conserved structural features are discussed in relation to a number of South African variegate porphyria-causing mutations in the human enzyme.